rxstat › Classes › Immunosuppressants

Immunosuppressants: shortage status in Canada

8 of the 20 immunosuppressants rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Apremilast Widespread shortage 2 of 3 reported products affected Lenalidomide Widespread shortage 5 of 8 reported products affected · est. return Oct 16, 2026 Adalimumab (Hulio) Partial shortage 1 of 9 reported products affected Apremilast Partial shortage 1 of 1 reported products affected · est. return Oct 9, 2026 Basiliximab (Simulect) Partial shortage 1 of 1 reported products affected Cyclosporine (Restasis Multidose) Partial shortage 2 of 9 reported products affected · est. return Mar 31, 2028 Mycophenolate Mofetil (Cellcept) Partial shortage 4 of 16 reported products affected Pirfenidone (Esbriet) Partial shortage 3 of 10 reported products affected Tocilizumab (Tyenne) Shortage anticipated 0 of 12 reported products affected Abatacept (Orencia) No current shortage Azathioprine (Imuran) No current shortage Canakinumab (Ilaris) Discontinued 0 of 1 reported products affected Daclizumab Beta (Zinbryta) Discontinued 0 of 1 reported products affected Etanercept (Rymti) No current shortage Ixekizumab (Taltz) No current shortage Mycophenolic Acid No current shortage Siltuximab (Sylvant) No current shortage Sirolimus (Rapamune) No current shortage Tacrolimus (Protopic) No current shortage Water Etanercept (Enbrel) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.